In the first part of a two-part series, Ann Harrison interviews addiction treatment expert Dr. Howard Kornfeld about the FDA decision to reject the Lykos Therapeutics proposal for MDMA-assisted therapy.
Leaders in policy, investment, community care, and media will discuss the future of psychedelics in society during a discussion entitled “Psychedelics: Agents of Change” at NeueHouse Madison Square in New York City.
The Zendo Project psychedelic peer support service is refocusing to provide harm reduction education to mainstream festivals and community mental health services.
The Drug Enforcement Administration has released two notices in the Federal Register declaring plans over the next year to expand the production of psilocybin, psilocin, and ibogaine for use in new research and clinical trials.
Elizabeth Nielson, co-founder of Fluence, offers thoughts on the roll out of the 2025 psychedelic therapy program in Colorado and the opportunities it offers for mental health professionals.
Mindstate Design Labs has received approval for a Phase 1 clinical trial to investigate the use of its formulation of 5-MeO-MiPT which it hopes to combine with other drugs to target precise serotonin receptors and create future psychotropic therapies.
A multidimensional poet and performer provides some psychedelic poetry as an offering for the autumn equinox.
In the wake of the FDA’s rejection of Lykos Therapeutics’ proposal for MDMA-Assisted therapy for PTSD, a therapist advocates for wider access to ketamine-assisted psychotherapy.
Psychedelics for Climate Action (PSYCA) Establishes Week of Eco-Psychedelic Activism.
A trauma survivor’s experience with ketamine may offer new avenues for understanding the complex relationship between physical pain and mental health.
Lykos Therapeutics CEO Amy Emerson is being replaced by interim CEO Michael Mullette in a company restructuring that began after the FDA’s rejection of Lykos’ application for MDMA-Assisted Therapy for PTSD.
Psychedelics Orientation
Episode 1: “So You Want To Do Psychedelics?” Mareesa Stertz leads you through the questions to consider before your first journey.
For Patreon Members
Deep Dive #1: DMT. Dennis McKenna and John A. Chavez join Ken Jordan for a fascinating discussion about the Spirit Molecule and the latest research into endogenous psychedelics.
